Table 1.
Clinical characteristics of VHD patients (n=42).
| Variables | n (%) or mean±SD |
|---|---|
| Age (years) | 55.65±1.71 |
| Male/female (% male) | 22/20 (52.38%) |
| NYHA | |
| I | 2 (4.76%) |
| II | 28 (66.67%) |
| III | 10 (23.81%) |
| IV | 2 (4.76%) |
| EF (before surgery) | 63.41±1.54 |
| EF (after surgery) | 56.98±1.70 |
| NT-pro-BNP (before surgery) | 1412.10±402.41 |
| Creatinine | 89.37±4.87 |
| Uric acid | 446.00±20.87 |
| WBC count (109/L) | 7.00±0.29 |
| Neutrophil (109/L) | 4.07±0.24 |
| Neutrophilic percentage | 0.57±0.01 |
| Neutrophil-to-lymphocyte ratio | 2.07±0.14 |
| PLT | 224.34±9.05 |
| CPB duration (min) | 146.81±6.71 |
| Aortic cross-clamping duration (min) | 84.93±4.03 |
| Length of tracheal intubation (hour) | 33.13±15.52 |
| Length of ICU stay (day) | 2.70±0.65 |
| Length of hospital stay (day) | 29.74±1.73 |
The results are expressed as n (%) or mean±standard deviation (SD) CPB=cardiopulmonary bypass; EF=ejection fraction; ICU=intensive care unit; NT-pro-BNP=N-terminal pro B-type natriuretic peptide; NYHA=New York Heart Association; PLT=platelet; VHD=valvular heart disease; WBC=white blood cell